原料药
Topiramate
KDMF APIs
Topiramate
韩文名称 | 토피라메이트 |
|---|---|
分类 | 中枢神经系统药物 |
CAS No. | 97240-79-4 |
KDMF 登记号 | 20130912-170-I-365-10(2) 20160713-170-I-472-16(1) |
生产厂商 | Bal Pharma Limited Nifty Labs Pvt.,Ltd. |
规格 | USP |
品目信息
IUPAC Name | [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0²,⁶]dodecan-6-yl]methyl sulfamate |
|---|---|
Synonyms | 2,3:4,5-bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate 2,3:4,5-di-O-isopropylidene-β-D-fructopyranose sulfamate |
Description | Topiramate is a anti-epileptic drug used to manage seizures and prevent migraines. It was initially approved by the FDA in 1996. In 2004, topiramate was approved for the prevention of migraine in adults. Since 2012, the extended-release formulation has been approved in combination with phentermine for chronic weight management therapy in adults. Characteristics that distinguish topiramate from other antiepileptic drugs are a monosaccharide chemical structure containing a sulfamate, and 40% of its mass accounted for by oxygen. Interestingly, topiramate was discovered by chance when attempts were made to formulate a novel antidiabetic drug |
Certificate of Analysis | If you need more information, please contact us. |
如需规格书 · 检验成绩书等附加资料，请在咨询时一并提出。负责人确认后将回复您。（02-579-1056 · ace@acebiopharm.com）